Welcome to the dedicated Spotlight On Policy page, your central resource for curated, expert-driven coverage of pharmaceutical and health system policy across the United States, the United Kingdom, Europe, and the wider global landscape. US Policy updates News CDC cuts recommended childhood jabs from 17 to 11 The CDC has upended the childhood vaccination schedule, cutting the number of recommended shots in a move that has dismayed medical organisations. News Judge blocks HHS' 340B rebate pilot at 11th hour A federal judge in the US has granted a restraining order that will stop the 340B rebate model from launching as planned on 1st January. News Trump raises spectre of drug pricing mandates for Medicare CMS unveils two more programmes in the Trump administration's efforts to cut drug prices, which have not been well received by the pharma industry. News Nine more companies sign pricing deals with Trump Nine more pharma groups have agreed to lower the costs of medicines in the US under the Trump administration's most favoured nation (MFN) scheme. more EU Policy updates R&D Europe has the tools to fight superbugs. Let’s use them. Data shows countries are off track – increasing the risk of profound health and economic consequences from AMR. Medical technologies can help. Market Access How are the US MFN and German MFG likely to impact pharmaceu... A comparison of the US MFN and German MFG. News Bayer gets EU approval for menopause drug Lynkuet Bayer now has approval on both sides of the Atlantic for Lynkuet, with the EU backing it for symptoms caused by both menopause and breast cancer. News Approvals extend use of Roche, AbbVie drugs in lymphoma Patients in the US and EU with follicular lymphoma have new treatment options, thanks to new approvals for CD20xCD3 bispecifics Lunsumio and Epkinly. more UK Policy updates News NICE endorses digital tools for people with asthma Eight digital health technologies (DHTs) designed to support people with asthma can be used by the NHS in England, according to NICE. News More details emerge of NHS online hospital due next year The NHS Online hospital, due to launch next year, will focus initially on nine common conditions, including menopause and prostate health. News Biosimilars unlock use of bevacizumab in bowel cancer by NHS More than 20 years after its approval, NICE has backed the use of bevacizumab as a treatment for colorectal cancer for the first time. R&D Big promises, hard work: What 2026 will demand from pharma Eloise McLennan looks at a set of signals areas where pressure is building and 2026 looks set to demand more clarity, discipline, and follow-through. more
News CDC cuts recommended childhood jabs from 17 to 11 The CDC has upended the childhood vaccination schedule, cutting the number of recommended shots in a move that has dismayed medical organisations.
News Judge blocks HHS' 340B rebate pilot at 11th hour A federal judge in the US has granted a restraining order that will stop the 340B rebate model from launching as planned on 1st January.
News Trump raises spectre of drug pricing mandates for Medicare CMS unveils two more programmes in the Trump administration's efforts to cut drug prices, which have not been well received by the pharma industry.
News Nine more companies sign pricing deals with Trump Nine more pharma groups have agreed to lower the costs of medicines in the US under the Trump administration's most favoured nation (MFN) scheme.
R&D Europe has the tools to fight superbugs. Let’s use them. Data shows countries are off track – increasing the risk of profound health and economic consequences from AMR. Medical technologies can help.
Market Access How are the US MFN and German MFG likely to impact pharmaceu... A comparison of the US MFN and German MFG.
News Bayer gets EU approval for menopause drug Lynkuet Bayer now has approval on both sides of the Atlantic for Lynkuet, with the EU backing it for symptoms caused by both menopause and breast cancer.
News Approvals extend use of Roche, AbbVie drugs in lymphoma Patients in the US and EU with follicular lymphoma have new treatment options, thanks to new approvals for CD20xCD3 bispecifics Lunsumio and Epkinly.
News NICE endorses digital tools for people with asthma Eight digital health technologies (DHTs) designed to support people with asthma can be used by the NHS in England, according to NICE.
News More details emerge of NHS online hospital due next year The NHS Online hospital, due to launch next year, will focus initially on nine common conditions, including menopause and prostate health.
News Biosimilars unlock use of bevacizumab in bowel cancer by NHS More than 20 years after its approval, NICE has backed the use of bevacizumab as a treatment for colorectal cancer for the first time.
R&D Big promises, hard work: What 2026 will demand from pharma Eloise McLennan looks at a set of signals areas where pressure is building and 2026 looks set to demand more clarity, discipline, and follow-through.
